Valneva SE (VALN) Total Current Liabilities (2020 - 2026)

Valneva SE's (VALN) quarterly Total Current Liabilities came in at $110.3 million in Q1 2026, down 1.26% year-on-year from $111.7 million in Q1 2025, and up 1.53% quarter-over-quarter from $108.6 million in Q4 2025.

Valneva SE (VALN) Total Current Liabilities (2020 - 2026) Analysis & Trends

Valneva SE has disclosed Total Current Liabilities across 7 years of filings, most recently posting $110.3 million for Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $110.3 million, down 1.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $110.3 million (down 1.26% YoY), and the FY2025 annual result was $108.6 million, down 11.27% from the prior year.
  • Total Current Liabilities came in at $110.3 million for Q1 2026 at Valneva SE, up from $108.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $465.4 million in Q2 2022 to a low of $108.6 million in Q4 2025.
  • The 5-year median for Total Current Liabilities is $170.9 million (2023), against an average of $212.6 million.
  • Across the five-year window, Total Current Liabilities plunged 57.95% in 2024 and soared 46.75% in 2025, its largest moves.
  • Valneva SE's Total Current Liabilities stood at $283.0 million in 2022, then sank by 39.6% to $170.9 million in 2023, then fell by 28.37% to $122.4 million in 2024, then dropped by 11.27% to $108.6 million in 2025, then grew by 1.53% to $110.3 million in 2026.
  • The last three Total Current Liabilities figures came in at $110.3 million (Q1 2026), $108.6 million (Q4 2025), and $175.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 1.70 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 16.35 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 636.40 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 13.42 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 3.88 Bn
9 Abivax 94.26 Bn 94.26 Bn - 72.86 Mn
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn 110.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 110.31 Mn
Dec 31, 2025 108.64 Mn
Sep 30, 2025 175.92 Mn
Jun 30, 2025 142.24 Mn
Mar 31, 2025 111.71 Mn
Dec 31, 2024 122.44 Mn
Sep 30, 2024 119.88 Mn
Jun 30, 2024 110.37 Mn
Mar 31, 2024 126.11 Mn
Dec 31, 2023 170.93 Mn
Sep 30, 2023 237.48 Mn
Jun 30, 2023 262.48 Mn
Mar 31, 2023 282.57 Mn
Dec 31, 2022 283.01 Mn
Sep 30, 2022 377.31 Mn
Jun 30, 2022 465.37 Mn
Mar 31, 2022 407.70 Mn
Dec 31, 2021 422.10 Mn
Dec 31, 2020 209.69 Mn